CIK 0001645460
- Non-accelerated filer
- Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473324577
- Phone
- +1 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- 4 Open-market sale Director sold 24,700 shares at an average $16.28 ($402,209)
- 4 Open-market sale Director sold 36,647 shares at an average $17.20 ($630,352)
- 4 Open-market sale Director sold 24,732 shares at an average $15.94 ($394,114)
- 4 Shares withheld for taxes President and CSO gave up 12,087 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO and President bought 1,377 shares at $7.26 ($9,997)
- 4 Open-market buy SVP, General Counsel and Sec bought 16,938 shares at an average $7.83 ($132,658)
- 4 Open-market buy CEO and President bought 3,000 shares at $6.90 ($20,700)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Director bought 10,000 shares at $4.81 ($48,100)
- 4 Derivatives Options or other derivatives
Page 10 of 13 · 259 filings